Repare Therapeutics Inc. (RPTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Repare Therapeutics Inc.

    NASDAQ: RPTX · Real-Time Price · USD
    1.76
    0.03 (1.73%)
    At close: Sep 10, 2025, 3:59 PM
    1.74
    -1.14%
    After-hours: Sep 10, 2025, 06:06 PM EDT

    Repare Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 53.48M 51.13M 131.83M 7.6M
    Cost of Revenue
    		 1.92M 13.24M 4.18M 3.34M
    Gross Profit
    		 40.1M 37.89M 15.11M -80.25M
    Operating Income
    		 -93.52M -116.22M -19.8M -108.66M
    Interest Income
    		 10.39M 13.33M 5.63M 259K
    Pretax Income
    		 -83.25M -103.18M -13.9M -108.59M
    Net Income
    		 -84.69M -93.8M -29.05M -106.91M
    Selling & General & Admin
    		 29.68M 33.76M 32.56M 26.21M
    Research & Development
    		 115.94M 133.59M 119.07M 90.05M
    Other Expenses
    		 -12M -13.24M -116.72M -87.85M
    Operating Expenses
    		 133.62M 154.12M 34.9M 28.41M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 147M 167.36M 151.63M 116.26M
    Income Tax Expense
    		 1.44M -9.38M 15.15M -1.68M
    Shares Outstanding (Basic)
    		 42.41M 42.09M 41.92M 37.82M
    Shares Outstanding (Diluted)
    		 42.41M 42.09M 41.92M 37.82M
    EPS (Basic)
    		 -2 -2.23 -0.69 -2.83
    EPS (Diluted)
    		 -2 -2.23 -0.69 -2.83
    EBITDA
    		 -90.22M -114.27M -17.82M -107.19M
    EBIT
    		 -92.14M -116.22M -19.8M -108.66M
    Depreciation & Amortization
    		 1.92M 1.95M 1.98M 1.47M

    Add to Watchlist